Diabetes & Metabolism

Redesign of Online ASN Journals Ready to Improve User Experience

The Journal of the American Society of Nephrology (JASN) and the Clinical Journal of American Society of Nephrology (CJASN) online platforms have been relaunched with increased functionality and a new interface providing readers with an on-the-go experience designed for all devices.

The relaunched sites with their modern design, contain numerous new features and functions making the reader experience easier and more efficient – thereby helping ensure that readers and authors can find what they’re looking for when they need it.

Dr. Shivam Joshi speaks about plant-based diets and the relationship with CKD in recent study: "Adequacy of Plant-Based Proteins in Chronic Kidney Disease”

A recent study was published online in the Journal of Renal Nutrition entitled “Adequacy of Plant-Based Proteins in Chronic Kidney Disease” on August 16, 2018. To get a behind-the-scenes look into the recent study, Kidney News Online asked Dr. Shivam Joshi, a physician and faculty member at the New York University School of Medicine, to answer several questions about the findings and what they mean for the future.

Q&As with ASN Foundation Grant Recipients 2018

The following articles are brief Q&A sessions with American Society of Nephrology (ASN) grant recipients. The sessions explore what research the individual is undertaking with the grant funds, their hopes for the research, career goals, and advice for others interested in applying for these grant funds.


ASN Pre-Doctoral Fellowship Awardimages_pag_thumb.png

Jiahua Li, MD, PhD - Ben J. Lipps Research Fellowship Award (2018)

Name: Jiahua Li, MD, PhD

Institution: Brigham and Women's Hospital

Grant: Ben J. Lipps Research Fellowship Award (2018)

Project Title: Targeting Proximal Tubule Metabolism in AKI to CKD Transition in Diabetic Nephropathy.
 

How would you sum up your research in one sentence?

Communities Weekly Rewind: Hope and Innovation in Nephrology

Months of efforts by ASN staff culminated on April 26, 2018, when ASN signed a Memorandum of Understanding with the Department of Health and Human Services to establish the Kidney Innovation Accelerator, KidneyX.

Newly Launched KidneyX Aims to Accelerate the Commercialization of Innovative Therapies in Kidney Care

ASN and the U.S. Department of Health and Human Services (HHS) have sent a clear signal in their desire to have new therapies in the kidney space through the signing of a Memorandum of Understanding establishing the Kidney Innovation Accelerator (KidneyX), a collaborative environment in which a community of researchers, innovators, and investors can participate.

U.S. Opioid Crisis: July Special Section


The July issue of Kidney News features a special section on the US opioid epidemic and the correlation with kidney disease.

 

Interactive Map

NY Times: Diabetes in Pregnancy Raises Risk of Heart Disease

The women who had gestational diabetes were 20 times as likely as controls to develop Type 2 diabetes, consistent with previous studies, and the risk was highest in the first year after giving birth. In addition, these women were 2.8 times as likely to have heart disease, and nearly twice as likely to develop high blood pressure. The researchers controlled for age, body mass index, ethnicity, smoking and other variables.

FDA approved new type II diabetes drug

The new drug, developed by Merck & Co and Pfizer Inc., is an oral drug known generically as ertugliflozin and in the class of SGLT2 inhibitors, which work to expel excess glucose through urine.


The US Food and Drug Administration (FDA) approved the drug early this week. The drug is expected to be available for sale in early 2018.

Obesity and Kidney Disease: addressing hyperfiltration, diet, and caloric restriction

Public policy efforts to address the obesity epidemic must include the nephrology community because obesity among young adults substantially heightens lifetime risk of ESRD.  Strong attention to blood pressure control and dietary factors may help mitigate CKD risk and its progression.

Pages